LSD plus psychotherapy may benefit dying patients, study says

03/18/2014 | Medscape (free registration)

The first controlled study of the use of lysergic acid diethylamide as part of psychotherapy in more than 40 years found it may help reduce anxiety in patients with terminal illness, according to Swiss investigators. Researchers writing in the Journal of Nervous and Mental Disease said the results of the 12-person pilot study, in which eight patients received LSD, warrant larger controlled trials.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY